Product Information

OXYBUTYNIN CL ER 10 MG TABLET is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.0978 per EA under NDC 68382025601. Its NADAC has been published 433 times since May 9, 2018.

FDA first approved this application on Jun 26, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

OXYBUTYNIN CL ER 10 MG TABLET

oxybutynin
$0.0978per EA

Strength

10 mg/1

NDC

68382025601

Classification

Generic

Dosage Form

TABLET, FILM COATED, EXTENDED RELEASE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

OXYBUTYNIN CHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA202332

FDA Approved

6/26/2017

TE Code

AB

On Market Since

8/10/2017

Pharmacological Classes

Cholinergic Muscarinic Antagonist
Cholinergic Muscarinic Antagonists

Price Statistics

The NADAC for OXYBUTYNIN CL ER 10 MG TABLET has been published 433 times since May 9, 2018, and over the history we have for it it has declined 75.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0978 per EA
All-time high$0.4299 (Jul 10, 2019)
All-time low$0.0837 (Nov 20, 2024)
52-week high$0.1089
52-week low$0.0978
Median price$0.1459
Average price$0.1918
Largest weekly change+35.2% (Jun 19, 2024)
Weeks tracked433
Tracking sinceMay 9, 2018

Price History

1W

-1.1%

1M

-1.1%

3M

-5.1%

6M

-6.3%

1Y

-9.2%

3Y

-14.3%

5Y

-49.6%

All

-75.8%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of OXYBUTYNIN CL ER 10 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for OXYBUTYNIN CL ER 10 MG TABLET, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.0978 per EA (NDC 68382025601), effective Aug 19, 2026.

How has the price of OXYBUTYNIN CL ER 10 MG TABLET changed over time?

Over the history we have for it, the NADAC for OXYBUTYNIN CL ER 10 MG TABLET has declined 75.8%. It has been tracked across 433 weekly CMS publications since May 9, 2018.

What are the highest and lowest recorded NADAC prices for OXYBUTYNIN CL ER 10 MG TABLET?

Since May 9, 2018, the NADAC for OXYBUTYNIN CL ER 10 MG TABLET has ranged from a low of $0.0837 (Nov 20, 2024) to a high of $0.4299 (Jul 10, 2019), with a median of $0.1459 per EA.

Are there cheaper alternatives to OXYBUTYNIN CL ER 10 MG TABLET?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as OXYBUTYNIN CL ER 10 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures OXYBUTYNIN CL ER 10 MG TABLET?

OXYBUTYNIN CL ER 10 MG TABLET (NDC 68382025601) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.